Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
NeoGenomics $316.25 million convertible senior notes offering
We advised the initial purchasers on the offering
SOPHiA GENETICS $57.5 million follow-on offering
We advised SOPHiA GENETICS on the offering
PTC Therapeutics $550 million convertible senior notes offering
We advised the initial purchasers on the offering
TARGAN sale to Merck Animal Health
We are advising TARGAN on the transaction
IDEAYA Biosciences $345 million equity offering
We advised the joint book-running managers and underwriters on the offering
Novanta $300 million private placement
We advised the placement agents on the transaction
GSK $10.6 billion acquisition of Nuvalent
We are advising GSK on the transaction
Inotiv prepackaged chapter 11 filing and restructuring support agreement
We are advising an ad hoc group of first-lien lenders in connection with Inotiv’s chapter 11 proceedings
Inventiva $120 million underwritten offering
We advised the underwriters on the offering
Sumitomo Pharma ¥102.1 billion stock offering
We advised the joint lead managers and joint bookrunners on the offering